舒血宁合葛根素治疗冠心病不稳定型心绞痛的临床价值研究

目的：探讨舒血宁合葛根素治疗冠心病不稳定型心绞痛的临床价值,以供参考。方法：采集2013年11月至2014年5月期间来我院治疗的86例冠心病不稳定型心绞痛（UA）病患资料,将其随机分为观察组和对照组,对照组用常规治疗,观察组在常规治疗基础上加舒血宁合葛根素,观察比较两组临床病症、心脏功能、心电图及安全性变化。结果：观察组症状总有效率95.7%,心电图总有效率89.1%,左室射血分数（EF）（0.67±0.04）%,左室短轴缩短率（FS）（0.33±0.05）%;对照组依次为80.0%、75.0%、（0.56±0.02）%、（0.25±0.04）%。且观察组无不良反应,差异对比有统计学意义（P〈0.05）。结论：舒血宁合葛根素治疗UA疗效显著且安全,值得临床推广使用。

objective to investigate the blood shu ning in puerarin treatment the clinical value of coronary heart disease unstable angina. Methods to collect 2013- 2014, the hospital treatment of 86 cases of coronary heart disease, unstable angina were randomly divided into observation group and control group, compare two groups of clinical symptoms, the results observed group has no adverse reactions, contrast was statistically significant difference （P 〈0.05）. Conclusion shu ning and puerarin blood UA with obvious therapeutic effect and safety, worthy of clinical use.